A cell-based system for screening compounds which can inhibit Epstein-Barr virus oncoprotein LMP-1-mediated NF-kB pathway
碩士 === 長庚大學 === 基礎醫學研究所 === 95 === Nasopharyngeal carcinoma (NPC) has a higher incidence rate in Asian than in other areas of the world, especially in southern China, Taiwan, and Hong Kong. Epstein-Barr virus infection and the expression of its oncogene product, latent membrane protein 1 (LMP-1) is...
Main Authors: | Jo-Ping Hsieh, 謝若屏 |
---|---|
Other Authors: | Jau-Song Yu |
Format: | Others |
Language: | en_US |
Published: |
2007
|
Online Access: | http://ndltd.ncl.edu.tw/handle/45402515853154997128 |
Similar Items
-
Cloning and expression of LMP1of Epstein-Barr virus
by: Yunn-ru Pan, et al.
Published: (1999) -
Interaction of Epstein - Barr virus LMP1 and hPRA1 and its effect on LMP1-medicated NF-kappaB activation
by: Ho-Yu Yeh, et al.
Published: (2004) -
C-Terminal Farnesylation of UCH-L1 Plays a Role in Transport of Epstein-Barr Virus Primary Oncoprotein LMP1 to Exosomes
by: E. Kobayashi, et al.
Published: (2018-02-01) -
Epstein - Barr virus transforming protein LMP-1 alters B cells gene expression by promoting accumulation of the oncoprotein ΔNp73α.
by: Rosita Accardi, et al.
Published: (2013-03-01) -
Epstein-Barr Virus Gene Expressions and the Role of the Viral Oncoprotein LMP2A in Regulation of Human UDP-Glucose Dehydrogenase Gene and Cell Migration
by: Yun-Ru Pan, et al.
Published: (2008)